Leo Martinez
Skin & Regenerative Health Writer
Leo writes about skin, hair, and tissue regeneration research. He built his beat reviewing cosmetic ingredient claims, which made him allergic to before and after promises.
FDA Approves Atezolizumab Combination for Stage III Colon Cancer
FDA approved atezolizumab with chemotherapy for Stage III dMMR colon cancer after a trial showed major disease free survival gains.
KPV Peptide Research Overview: What Studies Show About This Anti Inflammatory Tripeptide
KPV is a three amino acid fragment of alpha MSH studied in animal models for gut and skin inflammation, not an approved drug.
FDA Approves Third FOP Treatment, Atebrioz
FDA approved Atebrioz, an oral drug that reduced new bone growth in a placebo controlled trial for FOP patients.
Kisspeptin: The Reproductive Signaling Peptide
Kisspeptin sits at the top of the reproductive hormone cascade, and researchers are studying its role in fertility, pregnancy, and sexual behavior.
FDA Approves First Muscle Targeting Therapy for Spinal Muscular Atrophy
The FDA approved apitegromab, the first SMA therapy aimed directly at muscle loss rather than the underlying gene defect.
Thymosin Alpha 1 and Immune Function Research
A look at thymosin alpha 1 research, its approved uses abroad, and what studies say about immune modulation.
Study Examines How Surfactants Affect Peptide Drug Stability
A new pharmaceutical science paper looks at how surfactants protect or fail to protect therapeutic peptides under physical stress.